Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Human microdosing strategy

Figure 2.10. The microdosing strategy for candidate selection offers the greatest benefit when a stop-development decision is made. This is because the exploratory IND does not forego the submission of a traditional IND to continue testing in the clinic. (IND, Investigational new drug mths, months FIH, First-in-human clinical study Ph1, Phase 1 clinical studies Ph2, Phase 2 clinical studies.)... Figure 2.10. The microdosing strategy for candidate selection offers the greatest benefit when a stop-development decision is made. This is because the exploratory IND does not forego the submission of a traditional IND to continue testing in the clinic. (IND, Investigational new drug mths, months FIH, First-in-human clinical study Ph1, Phase 1 clinical studies Ph2, Phase 2 clinical studies.)...
See other pages where Human microdosing strategy is mentioned: [Pg.88]    [Pg.110]    [Pg.112]    [Pg.113]    [Pg.113]    [Pg.115]    [Pg.88]    [Pg.110]    [Pg.112]    [Pg.113]    [Pg.113]    [Pg.115]    [Pg.114]    [Pg.115]    [Pg.116]    [Pg.154]    [Pg.401]    [Pg.69]    [Pg.277]    [Pg.1089]    [Pg.70]    [Pg.222]   
See also in sourсe #XX -- [ Pg.112 ]



SEARCH



Microdose

Microdosing

© 2024 chempedia.info